Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Steven Binenbaum

Surgery Eatontown, NJ Medical Doctor

NPI 1366628281 CMS profile 107088

10 Industrial Way E, Suite 104, Eatontown, NJ 07724

Open in the dashboard

General payments

$23,592

156 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Steven Binenbaum of Eatontown, NJ is reported in the CMS Open Payments database as having received $23,592 across 156 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,790 27
2024 General $2,259 18
2023 General $2,135 14
2022 General $2,244 15
2021 General $2,205 13
2020 General $2,925 12
2019 General $8,033 57

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Steven Binenbaum
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Steven Binenbaum were reported at $3,790. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Steven Binenbaum Surgery median Middle half National median
2019 $8,033 $253 $82–$1,521 $163
2020 $2,925 $131 $40–$706 $114
2021 $2,205 $168 $50–$904 $132
2022 $2,244 $224 $76–$1,218 $149
2023 $2,135 $253 $82–$1,255 $160
2024 $2,259 $279 $90–$1,381 $164
2025 $3,790 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. W. L. Gore & Associates, Inc. $9,076 59 payments
  2. Miromatrix Medical Inc. $2,614 1 payment
  3. Stryker Corporation $2,509 11 payments
  4. Intuitive Surgical, Inc. $2,282 15 payments
  5. Transenterix, Inc. $1,293 7 payments
  6. TELA Bio, Inc. $1,060 3 payments
  7. Medical Device Business Services, Inc. $1,039 11 payments
  8. Medtronic, Inc. $735 8 payments
  9. Ethicon US, LLC $721 13 payments
  10. Davol Inc. $383 4 payments
  11. Other $1,879 24 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $9,068 123 payments
  2. Travel and Lodging $8,068 24 payments
  3. Consulting Fee $4,404 4 payments
  4. Education $2,052 5 payments
Products named General payments · program years 2019–2025
  1. Miromesh $2,614 1 payment
  2. Da Vinci Surgical System $2,282 15 payments
  3. SPY-PHI SYSTEM $1,945 6 payments
  4. GORE ENFORM Preperitoneal Biomaterial $1,636 8 payments
  5. GORE SEAMGUARD Bioabsorbable Staple Line Reinforce $1,337 10 payments
  6. SEAMGUARD $1,325 8 payments
  7. Senhance Surgical Robotics System $1,293 7 payments
  8. GORE SYNECOR Biomaterial $1,281 6 payments
  9. HARMONIC Product Family $1,182 12 payments
  10. ECHELON FLEX Stapler $1,065 11 payments
  11. Other $10,913 105 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

17

Median for General Surgery: 59

Drug cost

$77

Median for General Surgery: $393

Branded share of claims

100%

Median for General Surgery: 28.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 17 $77

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 15,891 Part D prescribers listed as General Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 67 billing codes

Paid by Medicare

$63,267

Medicare's payments for the services billed

Medicare patients

100

Average age 75

Services billed

306

58 women, 42 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 60%
Ischemic heart disease 46%
Diabetes 38%
Depression 26%
Cancer 25%
Chronic kidney disease 23%
Atrial fibrillation 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

156 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record